Equities research analysts at HC Wainwright issued their FY2029 earnings estimates for Acrivon Therapeutics in a report issued on Wednesday, March 26th. HC Wainwright analyst E. Bodnar anticipates ...

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce that its subsidia ...

Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome ...

Shidong Wang is a leading expert in the life sciences industry, currently serving as the Associate Director of Life Sciences ...

CDI Labs Canada Inc., a leading provider of services for proteome-wide antibody profiling and target identification, today announced the launch of its Technology Access Program for custom peptide ...

Development alliance leverages Maxwell Biosciences’ Claromer Platform for antiviral and antibacterial therapeutics.

Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company ™, announces the start ...

Acrivon Therapeutics, Inc.’s ACRV share price has dipped by 30.24%, which has investors questioning if this is right time to ...

Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) will likely be posting its quarterly earnings results before the market ...

Providing the largest and most comprehensive, high sensitivity, protein biomarker analysis to advance pre-clinical research FREMONT, Calif., March 24, 2025 /PRNewswire/ -- Alamar Biosciences ...

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce ...